- Open Access
Effectiveness of upper limb functional electrical stimulation after stroke for the improvement of activities of daily living and motor function: a systematic review and meta-analysis
Systematic Reviews volume 6, Article number: 40 (2017)
Stroke can lead to significant impairment of upper limb function which affects performance of activities of daily living (ADL). Functional electrical stimulation (FES) involves electrical stimulation of motor neurons such that muscle groups contract and create or augment a moment about a joint. Whilst lower limb FES was established in post-stroke rehabilitation, there is a lack of clarity on the effectiveness of upper limb FES. This systematic review aims to evaluate the effectiveness of post-stroke upper limb FES on ADL and motor outcomes.
Systematic review of randomised controlled trials from MEDLINE, PsychINFO, EMBASE, CENTRAL, ISRCTN, ICTRP and ClinicalTrials.gov. Citation checking of included studies and systematic reviews. Eligibility criteria: participants > 18 years with haemorrhagic/ischaemic stroke, intervention group received upper limb FES plus standard care, control group received standard care. Outcomes were ADL (primary), functional motor ability (secondary) and other motor outcomes (tertiary). Quality assessment using GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria.
Twenty studies were included. No significant benefit of FES was found for objective ADL measures reported in six studies (standardised mean difference (SMD) 0.64; 95% Confidence Interval (CI) [−0.02, 1.30]; total participants in FES group (n) = 67); combination of all ADL measures was not possible. Analysis of three studies where FES was initiated on average within 2 months post-stroke showed a significant benefit of FES on ADL (SMD 1.24; CI [0.46, 2.03]; n = 32). In three studies where FES was initiated more than 1 year after stroke, no significant ADL improvements were seen (SMD −0.10; CI [−0.59, 0.38], n = 35).
Quality assessment using GRADE found very low quality evidence in all analyses due to heterogeneity, low participant numbers and lack of blinding.
FES is a promising therapy which could play a part in future stroke rehabilitation. This review found a statistically significant benefit from FES applied within 2 months of stroke on the primary outcome of ADL. However, due to the very low (GRADE) quality evidence of these analyses, firm conclusions cannot be drawn about the effectiveness of FES or its optimum therapeutic window. Hence, there is a need for high quality large-scale randomised controlled trials of upper limb FES after stroke.
PROSPERO: CRD42015025162, Date:11/08/2015
Stroke is defined as a clinical syndrome characterised by rapidly developing focal or global disturbance in cerebral function lasting more than 24 h or leading to death due to a presumed vascular cause . Globally, approximately 16 million people have a stroke each year  and in the UK, first-ever stroke affects about 230 people per 100,000 population each year . Stroke represents a cost to the UK economy of approximately £9 billion annually, of which £1.33 billion results from productivity losses .
Stroke often leads to significant impairment of upper limb function and is associated with decreased quality of life in all domains except for mobility . Few patients attain complete functional recovery ; this deficit impairs performance of activities of daily living (ADL), including self-care and social activities [7, 8]. ADL reflect the level of functional impairment in daily life and are therefore the most clinically relevant outcome measures in assessing recovery after stroke .
Functional electrical stimulation (FES) was well established as an intervention for motor rehabilitation. FES is the electrical stimulation of motor neurons such that muscle groups are stimulated to contract and create/augment a moment about a joint . Transcutaneous electrodes offer the most immediate and clinically viable treatment option as they are non-invasive and may permit home-based treatment.
There are various terms used in the literature to describe different forms of electrical stimulation, often inconsistently. Some authors define FES as electrical stimulation applied to a subject which causes muscle contraction. This passive modality is also referred to as neuromuscular electrical stimulation . Others define FES as electrical stimulation applied during a voluntary movement . This definition acknowledges the volitional component of physical rehabilitation and was used in this systematic review. The distinction is important because neuroimaging studies have identified different cortical mechanisms according to stimulation type [11–13]. Indeed, perfusion to the ipsilesional sensory-motor cortex and cortical excitability were increased with FES when compared to passive modalities of electrical stimulation [12–14]. These findings could indicate greater potential for volitional FES to induce neuroplasticity. This is believed to play an important role in neurorehabilitation  and is a key objective of post-stroke functional recovery .
FES has been widely researched for post-stroke lower limb rehabilitation; several systematic reviews [17–19] and national guidelines [20, 21] exist. Improvement in upper limb function is central to post-stroke rehabilitation as it positively affects ADL and quality of life . Yet, there is still a lack of clarity on the effectiveness of FES in post-stroke upper limb rehabilitation  despite systematic reviews having been undertaken [24–28]. In part, this is due to methodological limitations [27, 28] or the outdated nature of some existing reviews [24–26]. The latter was highlighted by a recent Cochrane overview of reviews calling for an up-to-date review and meta-analysis of randomised controlled trials (RCTs) related to electrical stimulation . A more recent systematic review found a significant improvement in motor outcomes with upper limb FES . However, this was based on a single meta-analysis that combined ADLs with upper limb-specific measures of functional motor ability, including studies where results were at risk of performance bias (intervention groups receiving greater duration of treatment than control groups) . Another found no improvement in motor function when FES was applied within 6 months of stroke . However, this predominantly included studies that applied electrical stimulation in the absence of volitional muscle contraction, confounding interpretation of the results. This inconsistency is reflected in the 2016 guidelines set by the Royal College of Physicians which recommends FES only in the context of clinical trials as an adjunct to conventional therapy .
This systematic review aims to elucidate the effectiveness of upper limb FES compared to standard therapy in improving ADL, in addition to motor outcomes, post-stroke. It represents an important addition to the literature that focuses on the use of volitional FES and, for the first time, distinguishes its effect on clinically relevant patient outcomes from surrogate markers of patient rehabilitation. This includes analyses based on patient sub-groups defined by the time after stroke at which FES was initiated.
This systematic review was registered a priori on PROSPERO (CRD42015025162)  and was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) statement (see Additional file 1) .
A systematic search of MEDLINE (Ovid), PsychINFO (Ovid), EMBASE (Ovid) and Cochrane Central Register of Controlled Trials databases from inception to 06/09/2015 was undertaken using a combination of free text and index terms for stroke, FES and upper limb. An example strategy is in Appendix 1. The following ongoing trial databases were also searched: International Standard Randomised Controlled Trials Number Registry, WHO International Clinical Trials Registry Platform and ClinicalTrials.gov. Citation checking was carried out on studies included in this review and existing systematic reviews to identify any further studies. Authors were contacted twice by email for original data where published study data was insufficient as to allow data analysis. Non-English language articles were translated where possible.
Inclusion criteria: population: patients >18 years diagnosed with ischaemic or haemorrhagic stroke. Intervention: intervention group receive transcutaneous FES applied to the peripheral nervous system of the upper limb defined as (a) applied to the skin externally and (b) during voluntary movement in addition to standard post-stroke rehabilitative therapy. Comparator: control groups receive standard post-stroke rehabilitative therapy alone, no between group differences other than the stimulation. Outcomes: ADL/motor outcomes recorded. Study design: RCTs and cross-over studies (only if randomised and controlled, such that first phase is equivalent to an RCT).
Exclusion criteria: (1) previous FES therapy in intervention or control group. (2) Other type of electrical stimulation used in intervention or control group. No other restrictions were placed on patient age, sex, ethnicity, time since stroke, baseline functional ability, publication date or language.
Two reviewers independently screened each title and abstract for relevance. Full texts of relevant articles were retrieved and assessed independently by two reviewers against the selection criteria. Disagreements between reviewers were discussed, and a third reviewer consulted if required.
Primary outcomes were those measures which directly assessed ADL. Secondary outcomes were those measures which assessed performance of a task that is not classified as an activity of daily living such as grasping and moving a cube. These were regarded as good surrogate outcomes of ADL and as such they were termed ‘functional motor ability’. Tertiary outcomes were any other measure of motor outcome: muscle tone, force generation, distance reached and range of active movement. Tertiary outcomes are regarded as poor surrogate outcomes which may not correlate with ADL. See Table S1 (Additional file 2) for full definitions of individual measurement instruments.
Data extraction, risk of bias and quality assessment
Participant baseline characteristics, FES parameters and relevant outcome data at all reported time points were extracted; for cross-over studies, data from the first phase only were extracted. Data were extracted and the Cochrane Collaboration’s Tool for Assessing Risk of Bias was applied to all included studies by two reviewers independently; overall risk of bias judgement made based on most frequently cited risk across the seven categories. Quality assessment was performed using GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria. Risk of bias and quality assessment information was considered in interpretation of findings.
For each outcome, data were collated and assessed for suitability for meta-analysis. Care was taken to avoid double-counting of control group participants in meta-analyses. Meta-analysis was undertaken using a random effects model due to an underlying assumption that, although studies were similar, they would be representative of a distribution of effects on the outcome rather than represent a single underlying effect. Where the same outcome was measured using different but comparable tools on a continuous scale, standardised mean difference was used. Mean difference was used elsewhere. The I 2 was reported as a measure of heterogeneity, as well as the 95% confidence interval. Comparable tools were regarded to be those classified as primary outcomes and separately those classified as secondary outcomes. Tertiary outcome classification includes several types of measures which are not all comparable.
Study results reported as median, and interquartile ranges (IQR) were not included in meta-analyses. The shortest follow-up time post-stroke was used for analysis, for the purposes of consistency, as this was the most frequently reported time point. Where data were only represented graphically in papers, estimates were taken. Data that could not be incorporated into meta-analyses are reported narratively. Meta-analyses and forest plots were produced with Revman (version 5.35, Cochrane Collaboration). Separate analyses were undertaken for mean time post-stroke at which FES was initiated (less than 2 months; greater than 1 year).
The search strategy identified 603 records for screening; 135 studies proceeded to selection, of which two non-English language studies were translated. Twenty RCTs met the inclusion criteria. Six studies could not be assessed (Fig. 1). Details of excluded studies are in Appendix 2. Five possibly relevant ongoing clinical trials were identified (Appendix 3).
Details of the 20 included RCTsA1-A20 are presented in Table S2 (Additional file 2).
The included studies contained a total of 431 participants in the relevant intervention and control groups. Maximum group size was 28 participants and nine studiesA2-A5,A8,A12,A14,A15,A18 included fewer than ten participants in either group. For studies which reported these measures, mean participant age was 60 (range: 45.5–66.4) and mean gender distribution was 68.8% male (range: 44.4–88.2). The mean time since stroke (across 15 studies) was 2.87 years with considerable variation: five studiesA12,A13,A16,A19,A20 reporting mean times less than 2 months, fiveA4,A9,A15,A17,A18 reporting mean times between 1 and 3 years and sixA1,A2,A5-A7,A14 reporting mean times over 3 years. Note one studyA16 reported that all patients were treated within 60 days of stroke onset, hence mean time since stroke was less than 2 months, but it did not report a specific mean time. Of the 13 studiesA2,A4-A8,A10,A12-A16,A20 which reported stroke site, 49.0% of participants (range: 9.1–75.0) had a left hemisphere stroke (all means are weighted by participant number in studies). There was also variation within and between studies in the severity of post-stroke impairment.
Interventions and comparators
Two hundred thirty-eight participants received FES. For studies which reported FES parameters frequency ranged 20–50 Hz, peak current ≤ 70 mA and duration of stimulation from 3 to 10 s. Muscles stimulated included deltoid, triceps and the wrist and finger extensors/flexors.
One hundred ninety-three participants received a control treatment. Both intervention and control groups received standard care, which varied between studies but typically included physiotherapy, occupational therapy, task-based activities or other exercise-based interventions. In addition, three studies utilised orthosesA1,A6,A16, one utilised botulinum toxinA7 and one utilised mirror therapyA20. Three control groups also received sham FES, where a stimulation device delivered either no current at all or a sub-threshold currentA6,A7,A18. Within all included studies control and intervention groups received equivalent total therapy durations, median session duration is 45 min, minimising the risk of performance bias.
Risk of bias and quality assessment
Table S3 (Additional file 2) details the full critical appraisal information.
Included studies span a range of methodological quality. Nine studies were considered low risk of bias A5,A7,A9,A13,A14,A16-A19. One study was considered high riskA8. The remaining ten studiesA1-A5,A10-A12,A15,A20 were considered at an overall unclear risk of bias. Only the sham controlled studiesA6,A7,A18 were considered to have adequate participant blinding.
Quality assessment using GRADE criteria found very low quality evidence in all analyses performed as a result of the heterogeneity, low participant numbers and lack of blinding in most studies.
Activities of daily living
At least one measure of ADL (e.g. dressing and grooming) was reported by nine studiesA6-A8,A10-A13,A16,A19. Seven studies provided data suitable for meta-analysis; of the other two, one provided insufficient dataA8 and the other medians and interquartile rangesA10. Meta-analysis of results obtained through objectively assessed measures of ADLA6,A7,A11-A13,A19 was carried out separately from those that relied on patient recall, which may be at risk of recall bias. No difference was found between FES and control groups for the objectively obtained measures (SMD 0.64; CI [−0.02, 1.30]; I 2 = 66%) (Fig. 2a). Sensitivity analysis demonstrated that this effect was conserved when only sham-controlled studies were included in meta-analysis (Additional file 3: Figure S1).
An analysis of studies where FES was initiated in the acute phaseA12,A13,A19 (mean time post-stroke less than 2 months) showed a significant benefit of FES (SMD 1.24; CI [0.46, 2.03]; I 2 = 43%) and moderate statistical heterogeneity (Fig. 2b). In contrast, where FES was initiated more than 1 year (mean time) after strokeA6,A7,A11, no significant improvements were seen (SMD −0.10; CI [−0.59, 0.38]; I 2 = 0%) (Fig. 2c).
Francisco et al. (1998)A8, which could not be included in this meta-analysis for reasons outlined above, also initiated FES within 2 months and reported a statistically significant improvement in functional independence measure (FIM). Similarly, Mangold et al. (2009) A10 reported a significant improvement in extended Barthel index hand function subscore; patients were also treated on average within 2 months post-ictus.
Visual representation of all of the ADL data for meta-analysis is shown in Fig. 2d. No summary estimate is given due to inclusion of multiple ADL scales within several of the included studies. To combine these data in a meta-analysis, an arbitrary choice would have been made on which ADL scales to use from studies that use more than one measure of ADL. The figure indicates variable effect of FES although there seems to be a preponderance of data favouring a positive or no overall benefit.
Measures of functional improvement which do not incorporate ADL, were reported by 17 studiesA1-11,A14-A20 (of which 4 presented data graphicallyA2,A3,A5,A19, 2 only reported narrative resultsA2,A17 and 2 reported medians and IQRA5,A10). Many tools were used in these studies to measure functional improvements. The findings are displayed in a forest plot for visual comparison (Fig. 3c) identifying no consistent trend across secondary outcomes. Some studies showed individual improvementA6,A9,A15,A19,A20. Again, similarly to ADL analyses, secondary outcome data were not pooled because where studies utilised more than one scale in this category, an arbitrary choice would have to be made on which to include to avoid double counting of participants.
Separate analysis with pooled totals was performed for two of the tools: Fugl-Meyer Assessment (FMA) and Box and Block Test (BBT). Meta-analysis of seven studies reporting FMAA6,A7,A11,A14,A16,A19,A20 (Fig. 3a) showed a statistically significant improvement in upper limb motor function with FES corresponding to a clinically important difference (MD 6.72; CI [1.76, 11.68], I 2 = 62%). One study, Francisco 1998, could not be included in this meta-analysis and individually reported significant FMA improvement with FESA8. Further analysis based on mean time since stroke demonstrated a significant improvement in FMA where FES was initiated within 2 months after stroke (MD 11.11; CI [5.07, 17.16]; I 2 = 37%)A16,A19,A20. In studies where FES was initiated over 1 year (mean time) there was no significant improvement (MD 2.75; CI [−2.46, 7.95]; I 2 = 32%) (Additional file 4: Figure S2) A6,A7,A11,A14. Sensitivity analysis undertaken demonstrated that meta-analysis of sham-controlled studies did not favour FES; it should be noted that these studies initiated therapy after 1 year from stroke (mean) (Additional file 5: Figure S3).
Meta-analysis of BBT results showed no significant improvement with FESA5,A7,A15 (MD 5.34; CI [−0.06, 10.75]; I 2 = 54%) (Fig. 3b). FES was initiated on average more than 1 year after the stroke in these studies. The results of the studies that could not be included in this meta-analysisA2-A4 showed mixed results.
Other motor outcomes
These outcomes are assessed using tests that do not directly measure participant function but may contribute towards participant function in daily life, e.g. muscle tone or strength. These were reported in 14 studiesA1-A7,A9,A10,A13-A15,A19,A20, of which 2 reported median and IQRA5,A10, and a further two presented no SDA2,A3. Five of the seven studies that measured Modified Ashworth Scale (a measure of muscle tone) provided sufficient information for analysisA6,A7,A10,A13,A14 (Fig. 4a). Many of these reported muscle-specific tone, hence a quantitative meta-analysis could not be performed. Seven of the nine studies that reported force generation provided sufficient information for analysisA1,A4,A6,A7,A15,A19,A20. However, due to frequent reporting in muscle or movement-specific subscales, this could only be displayed as a visual representation (Fig. 4b). There was no clear trend observed. There was insufficient data to analyse distance reached or range of active movement.
The aim of this systematic review was to evaluate the effect of post-stroke upper limb FES on activities of daily living (ADL) and motor outcomes. The results bring new understanding of the effectiveness of FES on upper limb rehabilitation after stroke.
When FES was initiated within 2 months (mean time) of stroke, there was a significant improvement in ADL compared to the control group. No benefit was found when FES was initiated over 1 year since stroke. Although there was substantial heterogeneity in the analysis of the 1 year post-stroke subgroup, these findings fit with studies which have found that the majority of motor recovery after stroke occurs in the initial few months [32–34]. However, one must also interpret these findings in light of the risk of bias of included studies. All studies in less than two month group lack adequate participant blinding, whilst two out of the three included studies in the one year group used sham treatment. Furthermore, the overall evidence quality, assessed using GRADE criteria, was very low as a result of the substantial heterogeneity, low participant numbers and lack of blinding in most studies.
Meta-analysis performed on objective ADL measures, which are considered more reliable than self-reported measures, found no significant benefit of FES. Patient recall-based ADL measures may not reliably correlate with objective measures of patient activity and clinical improvement [35–38]. Human perception is influenced by many factors and cognitive biases , recall bias is one such factor that has been shown to result in large errors in patient reported outcomes .
Meta-analysis of FMA, the most commonly reported measurement instrument, showed a statistically significant benefit of FES corresponding to a moderate effect size. Additional analysis of FMA found a significant benefit for FES applied within 2 months of stroke but not for FES applied 1 year or more after stroke. Most included studies in these analyses were not adequately blinded and overall evidence quality was very low.
Meta-analysis of BBT results found no benefit from FES, but this could have been masked by the low group numbers: only 30 patients in total for the intervention groups and 24 in control groups. Indeed all studies included in this review had small group sizes, thus it is likely that these studies would lack the power necessary to demonstrate a small increase in upper limb motor function. Even a small improvement in function may be clinically significant, since upper limb function is so important for daily activities . An alternative explanation is that all studies which reported BBT applied FES 1 year or more after stroke, so the lack of improvement in BBT with FES could also reflect the fact that FES was not applied during the optimum therapeutic window. However, caution is needed when drawing conclusions about the optimum time window for FES post-stroke given the very low quality of evidence in the above analyses.
It is possible that FES is beneficial only when applied using certain stimulation parameters or when applied to a specific patient population. Indeed, variation in FES parameters including current, frequency, duration of stimulation and also in baseline function of participants both between and within studies were noted. It appears that there are no agreed stimulation parameters, and it is likely that none of the included studies employed exactly the same stimulation protocol. Potential benefits could thus be hidden among the inter-study variability between studies in this systematic review. This variability in FES parameters could influence results in this review and may be a contributing factor to the heterogeneity in the analyses.
Van Peppen et al.  found no improvement with FES in tertiary outcomes, specifically strength or dexterity. Bolton et al.  carried out a meta-analysis on five electromyography (EMG)-triggered neuromuscular stimulation studies and found an improvement across secondary outcomes as defined by the present systematic review. Meta-analysis by Meilink et al.  found no significant improvement in BBT. However, whilst the current review found a significant improvement in FMA, Meilink et al. did not. This discrepancy could be explained by the small meta-analysis group size of three studies in Meilink et al. compared to the eight studies here. Howlett et al.  conducted the most recent relevant systematic review. Whilst they found a significant improvement with upper limb FES compared to control, this finding was based on a single meta-analysis which combined primary and secondary outcomes as defined above. These outcomes are arguably not comparable. Moreover, such an approach prevents primary, secondary and tertiary outcomes from being independently assessed. To date, no systematic review has assessed the therapeutic window of upper limb FES application post-stroke.
Strengths and limitations
This systematic review is the most comprehensive and provides a much needed evaluation of upper limb-specific FES after stroke, which was missing from the literature. Analyses were performed, in accordance with the a priori protocol, enabling important conclusions about the use of FES in clinical practice to be drawn.
99% of the articles identified by our search strategy were assessed. However, it was not possible to translate four studies that were not in the English language and two articles could not be found after extensive attempts to locate them (see Appendix 2).
Meta-analyses gave rise to certain limitations. Firstly, included studies utilised many different measurement instruments and only a minority were employed by more than a few studies. Secondly, many studies used multiple measurement instruments for each outcome, e.g. several scales which measure ADL in a single study. As such, it was not appropriate to combine data in single meta-analyses. Thirdly, one study contained multiple relevant intervention groups but only a single control group for comparisonA4; the intervention group most similar to the other included studies was selected.
The small number and distribution of studies limited potential for formal between group comparisons in form of subgroup analyses. In addition, analyses on severity of stroke and stimulation parameters, which we had intended in our protocol, were not possible due to methodological variability.
All included studies, with the exception of oneA8 which could not be included in quantitative analysis, were considered at low or unclear risk of bias. Inadequate participant blinding was an issue in most studies.
Recommendations for clinical practice and research
This systematic review found insufficient evidence of clinical benefit to support routine use of FES in clinical practice; however, this may reflect a lack of high quality trials in the field which strongly supports the need for FES use in clinical trials.
This systematic review highlights the need for large RCTs in order to ensure homogeneity among groups and to have sufficient power to identify small functional improvements. Randomised triple-blinded controlled trials, where comparator groups receive sham treatment (subthreshold stimulation), are recommended as the optimal study design. An RCT that includes two intervention groups with FES applied at two different time points after stroke (e.g. 2 months and 1 year) could help clarify the optimal therapeutic window for FES. Future research should also attempt to identify the optimal FES parameters in order to standardise FES treatment for future studies.
It is advisable that prospective RCTs in this field use an agreed core outcome set unless there is a clear justification to use alternative measures  because the use of different but comparable measurement instruments limits the suitability of data for meta-analysis. Millar et al. are currently working on a core outcome set for upper limb rehabilitation after stroke to aid evidence-based clinical practice .
FES is a promising therapy which could play a part in future stroke rehabilitation strategies. This review found a statistically significant benefit from FES applied within 2 months of stroke on our primary outcome of ADL. However, due to the very low (GRADE) quality evidence of these analyses, firm conclusions about the effectiveness of FES or its optimum therapeutic window cannot be drawn. Hence, there is a need for high quality large-scale randomised controlled trials of upper limb FES after stroke.
Activities of daily living
Box and block test
Functional electrical stimulation
Functional independence measure
Prefered Reporting Items for Systematic Review and Meta-Analysis
Randomised controlled trial
Standardised mean difference
Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54(5):541–53.
Lynch CL, Popovic MR. Functional electrical stimulation. IEEE Control Syst Mag. 2008;28(2):40–50.
Rothwell PM, Coull AJ, Silver LE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet. 2005;366:1773–83.
Doucet BM, Lam A, Griffin L. Neuromuscular electrical stimulation for skeletal muscle function. Yale J Biol Med. 2012;85(2):201–15.
Franceschini M, La Porta F, Agosti M, et al. Is health-related-quality of life of stroke patients influenced by neurological impairments at one year after stroke? Eur J Phys Rehabil Med. 2010;46(3):389–99.
Kwakkel G, Kollen BJ, van der Grond J, et al. Probability of regaining dexterity in the flaccid upper limb: impact of severity of paresis and time since onset in acute stroke. Stroke. 2003;34(9):2181–6.
Lai SM, Studenski S, Duncan PW, et al. Persisting consequences of stroke measured by the stroke impact scale. Stroke. 2002;33(7):1840–4.
Sveen U, Bautz-Holter E, Sodring KM, et al. Association between impairments, self-care ability and social activities 1 year after stroke. Disabil Rehabil. 1999;21(8):372–7.
Clinical Knowledge Summary: Stroke and TIA. National Institute for Health and Care Excellence. http://cks.nice.org.uk/stroke-and-tia. Published February, 2009. Updated December, 2013. Accessed 1 Jan 2016.
Chae J, Sheffler L, Knutson J. Neuromuscular electrical stimulation for motor restoration in hemiplegia. Top Stroke Rehabil. 2008;15(5):412–26.
Hara Y. Rehabilitation with functional electrical stimulation in stroke patients. Int J Phys Med Rehabil. 2013;1(6):147.
Hara Y, Obayashi S, Tsujiuchi K, et al. The effects of electromyography-controlled functional electrical stimulation on upper extremity function and cortical perfusion in stroke patients. Clin Neurophysiol. 2013;124(10):2008–15.
Joa KL, Han YH, Mun CW, et al. Evaluation of the brain activation induced by functional electrical stimulation and voluntary contraction using functional magnetic resonance imaging. J Neuroeng Rehabil. 2012;9:48.
Barsi GI, Popovic DB, Tarkka IM, et al. Cortical excitability changes following grasping exercise augmented with electrical stimulation. Exp Brain Res. 2008;191(1):57–66.
Nahum M, Lee H, Merzenich MM. Principles of neuroplasticity-based rehabilitation. Prog Brain Res. 2013;207:141–71.
Takeuchi N, Izumi S. Rehabilitation with poststroke motor recovery: a review with a focus on neural plasticity. Stroke Res Treat. 2013;2013:128641.
Pereira S, Mehta S, McIntyre A, et al. Functional electrical stimulation for improving gait in persons with chronic stroke. Top Stroke Rehabil. 2012;19(6):491–8.
Robbins SM, Houghton PE, Woodbury MG, et al. The therapeutic effect of functional and transcutaneous electric stimulation on improving gait speed in stroke patients: A meta-analysis. Arch Phys Med Rehabil. 2006;87(6):853–9.
Roche A, Laighin G, Coote S. Surface-applied functional electrical stimulation for orthotic and therapeutic treatment of drop-foot after stroke - a systematic review. Phys Ther Rev. 2009;14(2):63–80.
Functional electrical stimulation for drop foot of central neurological origin. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ipg278. Published January, 2009. Updated January 9th, 2012. Accessed 1 Jan 2016.
National clinical guideline for stroke. Royal College of Physicians. https://www.rcplondon.ac.uk/guidelines-policy/stroke-guidelines. Published Fifth Edition October, 2016. Accessed 13 Oct 2016.
Veerbeek JM, Kwakkel G, van Wegen EE, et al. Early prediction of outcome of activities of daily living after stroke: a systematic review. Stroke. 2011;42(5):1482–8.
Stroke rehabilitation in adults. National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/cg162. Published June 2013. Accessed 1 Jan 2016.
Meilink A, Hemmen B, Seelen HA, et al. Impact of EMG-triggered neuromuscular stimulation of the wrist and finger extensors of the paretic hand after stroke: A systematic review of the literature. Clin Rehabil. 2008;22(4):291–305.
Van Peppen RP, Kwakkel G, Wood-Dauphinee S, et al. The impact of physical therapy on functional outcomes after stroke: What’s the evidence? Clin Rehabil. 2004;18(8):833–62.
Bolton DA, Cauraugh JH, Hausenblas HA. Electromyogram-triggered neuromuscular stimulation and stroke motor recovery of arm/hand functions: A meta-analysis. J Neurol Sci. 2004;223(2):121–7.
Howlett OA, Lannin NA, Ada L, et al. Functional electrical stimulation improves activity after stroke: a systematic review with meta-analysis. Arch Phys Med Rehabil. 2015;96(5):934–43.
Vafadar AK, Côté JN, Archambault PS, et al. Effectiveness of functional electrical stimulation in improving clinical outcomes in the upper arm following stroke: a systematic review and meta-analysis. BioMed Res Int. 2014;2015.
Pollock A, Farmer SE, Brady MC, et al. Interventions for improving upper limb function after stroke. Cochrane Database Syst Rev. 2014; 12(11)
Eraifej J, Clark W, France B, et al. Does upper limb transcutaneous functional electrical stimulation after stroke improve motor outcomes? http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015025162. Published August 11th, 2015. Updated January 11th, 2016. Accessed 23 June 2016.
Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. BMJ. 2009;339:b2535.
Jorgensen HS, Nakayama H, Raaschou HO, et al. Outcome and time course of recovery in stroke, part II: time course of recovery, the Copenhagen stroke study. Arch Phys Med Rehabil. 1995;76(5):406–12.
Lee KB, Lim SH, Kim KH, et al. Six-month functional recovery of stroke patients: a multi-time-point study. Int J Rehabil Res. 2015;38(2):173–80.
Kuptniratsaikul V, Kovindha A, Suethanapornkul S, Massakulpan P, Permsirivanich W, Kuptniratsaikul PS. Motor recovery of stroke patients after rehabilitation: one-year follow-up study. Int J Neurosci. 2016;29:1–7.
Bitzer EM, Petrucci M, Lorenz C, et al. A comparison of conventional and retrospective measures of change in symptoms after elective surgery. Health Qual Life Outcomes. 2011;9:23.
McPhail S, Haines T. Response shift, recall bias and their effect on measuring change in health-related quality of life amongst older hospital patients. Health Qual Life Outcomes. 2010;8:65.
Prince SA, Adamo KB, Hamel ME, et al. A comparison of direct versus self-report measures for assessing physical activity in adults: A systematic review. Int J Behav Nutr Phys Act. 2008;5:56.
Redelmeier DA, Dickinson VM. Determining whether a patient is feeling better: pitfalls from the science of human perception. J Gen Intern Med. 2011;26(8):900–6.
Reyes-Guzman ADL, Perez-Nombela S, Dimbwadyo-Terrer I, et al. Functional upper limb evaluation of activities of daily living in people with neurological disorders. In: Giroux J, Vallee G, editors. Activities of daily living: performance, impact on life quality and assistance. Hauppauge, New York: Nova Science Publishers; 2013. p. 55–76.
Williamson PR, Altman DG, Blazeby JM, et al. Developing core outcome sets for clinical trials: Issues to consider. Trials. 2012;13:132.
Millar J, Ali M, Pollock A, et al. Standardisation of outcome measures in trials of upper limb rehabilitation after stroke. http://www.comet-initiative.org/studies/details/653?result=true. Published October, 2014. Accessed 10 Jan 2016.
A1. Barker RN, Brauer S, Carson R. Training-induced changes in the pattern of triceps to biceps activation during reaching tasks after chronic and severe stroke. Exp Brain Res 2009;196(4):483–96.
A2. Cauraugh J, Light K, Kim S, et al. Chronic motor dysfunction after stroke: Recovering wrist and finger extension by electromyography-triggered neuromuscular stimulation. Stroke 2000;31(6):1360–64.
A3. Cauraugh JH, Kim S. Two coupled motor recovery protocols are better than one: Electromyogram-triggered neuromuscular stimulation and bilateral movements. Stroke 2002;33(6):1589–94.
A4. Cauraugh JH, Kim SB. Chronic stroke motor recovery: duration of active neuromuscular stimulation. J Neurol Sci 2003;215(1-2):13–19.
A5. Cauraugh JH, Kim SB. Stroke motor recovery: active neuromuscular stimulation and repetitive practice schedules. J Neurol Neurosurg Psychiatry. 2003;74(11):1562–66.
A6. Chan MK, Tong RK, Chung KY. Bilateral upper limb training with functional electric stimulation in patients with chronic stroke. Neurorehabil Neural Repair 2009;23(4):357–65.
A7. Duarte E, Marco E, Cervantes C, DÃ¬az D, Chiarella SC, Escalada F. Efectos de la toxina botulínica tipo A y electroestimulación en la espasticidad flexora distal de la extremidad superior en el ictus. ensayo clínico aleatorizado. Rehabilitacion (Madr). 2011;45(3):194–201.
A8. Francisco G, Chae J, Chawla H, et al. Electromyogram-triggered neuromuscular stimulation for improving the arm function of acute stroke survivors: A randomized pilot study. Arch Phys Med Rehabil 1998;79(5):570–75.
A9. Hara Y, Ogawa S, Tsujiuchi K, Muraoka Y. A home-based rehabilitation program for the hemiplegic upper extremity by power-assisted functional electrical stimulation. Disabil Rehabil. 2008;30(4):296–304.
A10. Mangold S, Schuster C, Keller T, et al. Motor training of upper extremity with functional electrical stimulation in early stroke rehabilitation. Neurorehabil Neural Repair 2009;23(2):184–90.
A11. McCabe J, Monkiewicz M, Holcomb J, Pundik S, Daly JJ. Comparison of robotics, functional electrical stimulation, and motor learning methods for treatment of persistent upper extremity dysfunction after stroke: A randomized controlled trial. Arch Phys Med Rehabil. 2015;96(6):981–90.
A12. Popovic MB, Popovic DB, Sinkjaer T, et al. Restitution of reaching and grasping promoted by functional electrical therapy. Artif Organs 2002;26(3):271–75.
A13. Popovic MB, Popovic DB, Sinkjaer T, et al. Clinical evaluation of functional electrical therapy in acute hemiplegic subjects. J Rehabil Res Dev 2003;40(5):443–53.
A14. Shimodozono M, Noma T, Matsumoto S, et al. Repetitive facilitative exercise under continuous electrical stimulation for severe arm impairment after sub-acute stroke: A randomized controlled pilot study. Brain Inj 2014;28(2):203–10.
A15. Shin HK, Cho SH, Jeon HS, et al. Cortical effect and functional recovery by the electromyography-triggered neuromuscular stimulation in chronic stroke patients. Neurosci Lett 2008;442(3):174–79.
A16. Shindo K, Fujiwara T, Hara J, et al. Effectiveness of hybrid assistive neuromuscular dynamic stimulation therapy in patients with subacute stroke: A randomized controlled pilot trial. Neurorehabil Neural Repair 2011;25(9):830–37.
A17. Tarkka IM, Pitkanen K, Popovic DB, et al. Functional electrical therapy for hemiparesis alleviates disability and enhances neuroplasticity. Tohoku J Exp Med 2011;225(1):71–6.
A18. Thorsen R, Cortesi M, Jonsdottir J, et al. Myoelectrically driven functional electrical stimulation may increase motor recovery of upper limb in poststroke subjects: A randomized controlled pilot study. J Rehabil Res Dev 2013;50(6):785–94.
A19. Thrasher TA, Zivanovic V, McIlroy W, et al. Rehabilitation of reaching and grasping function in severe hemiplegic patients using functional electrical stimulation therapy. Neurorehabil Neural Repair 2008;22(6):706–14.
A20. Yun GJ, Chun M, Parl JY, et al. The synergic effects of mirror therapy and neuromuscular electrical stimulation for hand function in stroke patients. Ann Rehabil Med 2011;35:316–21.
We would like to thank Professor Steve Sturman, Consultant Neurologist specialising in Neurology and Rehabilitation (Queen Elizabeth Hospital Birmingham, UK), for his clinical perspective and help in revising the manuscript.
No funding was sourced for this systematic review.
Availability of data and materials
Available on request.
Authors JE, WC, BF, SD and DM. Other contributor SS. JE, WC, BF, SD and DM contributed to the conception and design of the work and preparation of the a priori protocol. JE, WC, BF, SD were involved in the search, screening, selection, critical appraisal, data extraction and writing of the draft manuscript. JE and WC performed all statistical analyses and produced the forest plots. SD and BF produced the tables. JE, WC, BF, SD and DM contributed to revision of the draft manuscript and approval of the final version to be published. SS contributed to critical revision of the draft paper. JE is the corresponding author and guarantor.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. (DOC 60 kb)
Outcome Measure Definitions Table and References. Table S2. Included Study Characteristics Table and References. Table S3. Critical Appraisal Table. (DOC 171 kb)
SMD (95% CI) of Functional Electrical Stimulation (FES) vs control on Activities of Daily Living for sham-controlled trials only. AMAT Arm Motor Ability Test; CAHAI Chedoke Arm and Hand Activity Inventory; FIM Functional Independence Measure; UEFT Upper Extremity Function Test; HFG Higher Functioning Group; LFG Lower Functioning Group. (JPG 85 kb)
SMD (95% CI) of Functional Electrical Stimulation (FES) vs control on secondary outcomes (functional motor recovery) measured by FMA. a FES initiated within two months of stroke b FES initiatied after one year of stroke. (JPG 96 kb)
SMD (95% CI) of Functional Electrical Stimulation (FES) vs control on secondary outcomes (functional motor recovery) for sham-controlled trials only measured by FMA. (JPG 74 kb)
The following is the search strategy used to search databases on Ovid. The search terminology was adapted to meet Cochrane search requirements but remained otherwise unchanged. The same search strategy was used to identify both primary studies and systematic reviews, but the databases searched differed as outlined in the Methods section.
transcutaneous adj5 stimulat*
1 OR 2 OR 3 OR 4 OR 5 OR 6
brain* or cerebr*
isch?em* or thromb* or embol* or infarct*
12 AND 13
h?emorrhage or h?ematoma or bleed
12 AND 15
8 OR 9 OR 10 OR 11 OR 14 OR 16
18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26
7 AND 17 AND 27
Randomized Controlled Trials as Topic/
Controlled Clinical Trials as Topic/
clinical trials as topic/
randomized controlled trial.pt.
controlled clinical trial.pt.
(random* or RCT or RCTs).tw.
(controlled adj5 (trial* or stud*)).tw.
(clinical* adj5 trial*).tw.
((control or treatment or experiment* or intervention) adj5 (group* or subject* or patient*)).tw.
(quasi-random* or quasi random* or pseudo-random* or pseudo random*).tw.
((control or experiment* or conservative) adj5 (treatment or therapy or procedure or manage*)).tw.
((singl* or doubl* or tripl* or trebl*) adj5 (blind* or mask*)).tw.
(assign* or allocat*).tw.
28 and 54
exp animals/not humans.sh.
55 not 56
Excluded studies list
Ongoing studies list
About this article
Cite this article
Eraifej, J., Clark, W., France, B. et al. Effectiveness of upper limb functional electrical stimulation after stroke for the improvement of activities of daily living and motor function: a systematic review and meta-analysis. Syst Rev 6, 40 (2017). https://0-doi-org.brum.beds.ac.uk/10.1186/s13643-017-0435-5
- Functional electrical stimulation
- Upper limb
- Systematic review
- Meta-analysis, neurorehabilitation